Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Icu Medical (ICUI) EPS (Weighted Average and Diluted) (2016 - 2025)

Icu Medical's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at -$0.63 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 35.71% year-over-year to -$0.63, compared with a TTM value of $0.03 through Dec 2025, up 100.62%, and an annual FY2025 reading of $0.03, up 100.62% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.63 at Icu Medical, down from -$0.14 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $1.43 in Q3 2021, with the low at -$1.63 in Q1 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.22, with a median of -$0.48 recorded in 2023.
  • Year-over-year, EPS (Weighted Average and Diluted) plummeted 550.0% in 2024 and then surged 262.5% in 2025.
  • Tracing ICUI's EPS (Weighted Average and Diluted) over 5 years: stood at $0.91 in 2021, then crashed by 170.33% to -$0.64 in 2022, then decreased by 10.94% to -$0.71 in 2023, then crashed by 38.03% to -$0.98 in 2024, then soared by 35.71% to -$0.63 in 2025.
  • Per Business Quant, the three most recent readings for ICUI's EPS (Weighted Average and Diluted) are -$0.63 (Q4 2025), -$0.14 (Q3 2025), and $1.43 (Q2 2025).